Why not Intravenous Thrombolysis in Patients with Recurrent Stroke within 3 Months?

Acute ischemic stroke continues to be a very severe disorder that has significant impact on human health. Its treatment options are limited and alteplase remains the only American Food and Drug Administration-approved drug for patients with acute ischemic stroke. Furthermore, intravenous thrombolysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chuanjie, Wu, Di, Chen, Jian, Li, Chuanhui, Ji, Xunming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JKL International LLC 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963351/
https://www.ncbi.nlm.nih.gov/pubmed/29896419
http://dx.doi.org/10.14336/AD.2017.0406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963351/
https://www.ncbi.nlm.nih.gov/pubmed/29896419
http://dx.doi.org/10.14336/AD.2017.0406

Ejemplares similares